食品科学 ›› 2022, Vol. 43 ›› Issue (11): 105-112.doi: 10.7506/spkx1002-6630-20210608-097

• 营养卫生 • 上一篇    下一篇

基于乙酰胆碱酯酶和氧化应激研究海胆酮对阿尔茨海默症的作用机制

张涛,陈艳红,常高萍,杨远帆,杜希萍,姜泽东,倪辉,李清彪   

  1. (1.集美大学海洋食品与生物工程学院,福建 厦门 361021;2.福建省食品微生物与酶工程重点实验室,福建 厦门 361021;3.厦门市食品与生物工程技术研究中心,福建 厦门 361021;4.厦门南方海洋研究中心海藻资源化利用与深加工重点实验室,福建 厦门 361021)
  • 出版日期:2022-06-15 发布日期:2022-06-30
  • 基金资助:
    国家自然科学基金海峡联合项目(U1805235);国家自然科学基金重点项目(22038012); 福建省科技厅重点项目(2018N0019);福建省科技经济融合服务平台项目(B21022)

Understanding the Mechanism of Action of Echinenone on Alzheimer’s Disease from the Perspective of Acetylcholinesterase and Oxidative Stress

ZHANG Tao, CHEN Yanhong, CHANG Gaoping, YANG Yuanfan, DU Xiping, JIANG Zedong, NI Hui, LI Qingbiao   

  1. (1. College of Ocean Food and Biological Engineering, Jimei University, Xiamen 361021, China; 2. Fujian Provincial Key Laboratory of Food Microbiology and Enzyme Engineering, Xiamen 361021, China; 3. Research Center of Food Biotechnology of Xiamen City, Xiamen 361021, China; 4. Key Laboratory of Systemic Utilization and In-depth Processing of Economic Seaweed, Xiamen Southern Ocean Technology Center of China, Xiamen 361021, China)
  • Online:2022-06-15 Published:2022-06-30

摘要: 海胆酮是一种酮式类胡萝卜素,主要从海胆及藻类等海洋生物中提取。本文研究海胆酮对乙酰胆碱酯酶(acetylcholinesterase,AChE)的抑制作用,应用酶动力学、荧光光谱、圆二色光谱和分子对接技术研究海胆酮对AChE的抑制机理,并用淀粉样β蛋白片段25~35(amyloid beta-peptide 25-35,Aβ25-35)诱导大鼠肾上腺嗜铬细胞瘤细胞(PC12细胞)建立阿尔茨海默症(Alzheimer’s disease,AD)模型,研究海胆酮对AD细胞模型氧化应激损伤的作用。结果表明,海胆酮有很强的AChE抑制活性,其半抑制质量浓度为(16.29±0.97)μg/mL,抑制常数Ki为3.82 μg/mL,表现为竞争性抑制;海胆酮可诱导AChE二级结构改变,更容易与AChE活性中心氨基酸Ser200、His440、Trp84和Tyr121结合,阻碍底物碘代硫代乙酰胆碱(acetylthiocholine iodide,ATCI)与酶结合,从而引起酶活力降低。海胆酮能有效抑制Aβ25-35诱导PC12细胞的AChE活力,降低丙二醛含量,增加超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶活力,减轻Aβ25-35诱导的PC12细胞氧化应激损伤。本研究基于AChE和氧化应激阐明了海胆酮对AD的潜在作用机制,为海胆酮在功能食品、生物医药等领域的应用提供了数据支持和理论根据。

关键词: 海胆酮;阿尔茨海默症;乙酰胆碱酯酶;分子对接;氧化应激

Abstract: Echinenone, a keto carotenoid, has been extracted mainly from marine organisms such as sea urchin and algae. In this work, the inhibitory effect of echinenone on acetylcholinesterase (AChE) was studied, and the underlying mechanism was elucidated by enzyme kinetics, fluorescence spectroscopy, circular dichroism spectroscopy and molecular docking. In addition, a cell model of Alzheimer’s disease (AD) was established by inducing rat adrenal pheochromocytoma PC12 cells with amyloid beta peptide 25-35 (Aβ25-35) to study the effects of echinenone on oxidative stress injury in the AD model. The results showed that echinenone had strong inhibitory effect on AChE, with a half-maximal inhibition concentration (IC50) value of (16.29 ± 0.97) μg/mL and an inhibition constant Ki of 3.82 μg/mL, and the inhibition was competitive. Echinenone could induce changes in the secondary structure of AChE, and it was more likely to bind to Ser200, His440, Trp84 and Tyr121 in the active center of AChE, hindering the substrate acetylthiocholine iodide (ATCI) from binding to the enzyme and, consequently, resulting in a decrease of the enzyme’s activity. Echinenone inhibited the activity of AChE in PC12 cells induced by Aβ25-35, reduced the content of malondialdehyde (MDA), and increased the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px), thus reducing oxidative stress damage of PC12 cells induced by Aβ25-35. The results of this study will provide data support and a theoretical basis for the application of echinenone in functional foods, biomedicine and other fields.

Key words: echinenone; Alzheimer’s disease; acetylcholinesterase; molecular docking; oxidative stress

中图分类号: